• US: +1-408-610-2300
  • Toll Free: +1-866-831-4085
  • Login / Register
Heparin Market Size & Share, 2026 | Global Industry Analysis Report

Heparin Market Analysis Report By Type, By Route of Administration, By Application Form, By End Use And Segment Forecasts From 2019 To 2026

Report ID: MN17620144  |  Published: October 2020  |  No of Pages: 80
Format: Electronic (PDF)  |  Industry: Pharmaceuticals  |  Publisher: Grand View Research

Industry Insights

The global heparin market size was valued at USD 6.49 billion in 2018. It is also estimated to witness 1.6% CAGR over the forecasted period, 2019 to 2026. Rising incidences associated with cardiovascular disorders and venous thromboembolisms are anticipated to drive the market growth.

The data published by the CDC (Centers for Disease Control), in 2018 stated that more than 900,000 people across the U.S. were affected by pulmonary embolism and vein thrombosis each year. These factors are anticipated to trigger the market demand in the upcoming years.

U.S. heparin marketSeveral biopharmaceutical companies have started investing hugely in R&D activities for new drug development. Also, organizations like NIH (National Institutes of Health) and CDC have started undertaking initiatives to increase the level of awareness among the individuals residing in the developing economies. Moreover, the rising demand for anticoagulants is also expected to boost market growth.

Type Insights

The global heparin market can be classified into unfractionated heparin, ultra-low molecular weight, and low molecular weight based on its type. In 2018, the segment of low molecular weight accounted for the highest share across the global market. This can be associated with the enhanced anticoagulant effect associated with these products.

A study by NEJM Journal Watch stated that reduced incidences of thrombocytopenia by induction of heparin have also contributed majorly towards increasing demand for this segment. The segment of ultra-low molecular weight is projected to account for the highest CAGR from 2019 to 2026 due to its enhanced pharmacological effects and product commercialization.

Route of Administration Insights

The global market can be segmented into subcutaneous and intravenous segments based on the route of administration. In 2018, the subcutaneous segment accounted for the largest share across the global market. It is also projected to register significant growth in the upcoming years on account of low hospitalization costs involved in this drug route.

Global heparin market

Moreover, the subcutaneous route of administration is generally preferred by the patients due to ease of drug administration, increasing preference for in house treatment, and reduced time associated with the treatment. Also, the reduction in the number of risks associated with systemic infection and enhanced quality of life are projected to trigger the market growth for this segment.

Application Insights

The global market can be segmented into atrial fibrillation, coronary artery disease, venous thromboembolism, and renal impairment based on its application. In 2018, the coronary artery disease segment accounted for the highest share across the global market on account of the rising number of incidences and prevalence of heart disorders.

The segment of venous thromboembolism is anticipated to witness the highest CAGR from 2019 to 2026. This segment can be further bifurcated into DVT (deep vein thrombosis) and PE (pulmonary embolism). Rising awareness about thrombosis among the millennial population is expected to augment the market growth for this segment.

End Use Insights

The global market can be classified into outpatients and inpatients based on its end-use. In 2018, the outpatients end-use segment accounted for the largest share across the global market. It is also expected to possess the highest CAGR of 2.4% from 2019 to 2026.

This growth can be associated with the rising preference of the subcutaneous drug administration route prevailing among the population. The reduction in the hospital costs for outpatients segment is expected to propel its market demand across the globe. Also, studies conducted by NCBI stated that outpatient therapy was less costly venous thromboembolism.

Regional Insights

North America accounted for a dominant share across the global market in 2018. This can be associated with the surging number of cardiovascular disorders and sports injuries among individuals residing across this region. Moreover, an increase in the expenditure on the healthcare sector, enhanced healthcare infrastructure, and higher patient awareness is expected to further fuel up market growth.

Asia Pacific is expected to witness the fastest growth across the global market from 2018 to 2026. This growth can be attributed to several factors such as improved healthcare infrastructure, emerging opportunities, several initiatives being undertaken by public and private organizations, and economic development across countries like China, India, and Japan are anticipated to augment the market demand in the upcoming years.

COVID-19 Impact Insights

The heparin market has been positively impacted due to the ongoing COVID-19 pandemic. An increase in the budget and expenditure on healthcare department by government across several countries has contributed majorly towards the market growth. Moreover, the rising number of cases across the globe has forced governing organizations to home isolate asymptomatic patients. This has triggered the demand for subcutaneous drugs. Also, as people having cardiovascular problems are being considered under the high-risk category, their care is the utmost priority of several countries. Such factors have also promoted new entrants to make huge investments for catering to the rising needs across the globe.

Heparin Market Share Insights

The key players operating in the market are Pfizer, Inc., Leo Pharma A/S, GlaxoSmithKline plc, Baxter, Sanofi, Aspen Holdings, Dr. Reddy’s Laboratories Ltd., Fresenius SE & Co. KGaA, and B. Braun Medical Inc. They are constantly engaged in product development and innovation to gain a cutting edge over other players.

Strategic initiatives such as acquisitions, mergers, and collaborations are also being undertaken by these players for widening the global product portfolio. For example, Fresenius Kabi had launched the heparin sodium in free flex bags that are ready-to-administer for expansion of their critical care products portfolio.

Report Scope

Attribute

Details

Base year for estimation

2018

Actual estimates/Historic data

2014 - 2017

Forecast period

2019 - 2026

Market representation

Revenue in USD Billion & CAGR from 2018 to 2026

Regional scope

North America, Europe, Asia Pacific, Latin America, MEA

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Country scope

U.S., Canada, U.K., Germany, France, Italy, Spain, Russia, Mexico, Brazil, Argentina, Japan, China, India, South Korea, Australia, Singapore, South Africa, UAE, Saudi Arabia

15% free customization scope (equivalent to 5-analyst working days)

If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization.


Segments Covered in the Report

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends from 2014 to 2026 in each of the sub segments. For the purpose of this study, Million Insights has segmented the global heparin market on the basis of type, route of administration, application, end use, and region:

• Type Outlook (Revenue, USD Million, 2014 - 2026)
    • Low Molecular Weight Heparin
    • Ultra-low Molecular Weight Heparin
    • Unfractionated Heparin

• Route of Administration Outlook (Revenue, USD Million, 2014 - 2026)
    • Intravenous
    • Subcutaneous

• Application Outlook (Revenue, USD Million, 2014 - 2026)
    • Venous Thromboembolism
    • Atrial Fibrillation
    • Renal Impairment
    • Coronary Artery Disease
    • Others

• End Use Outlook (Revenue, USD Million, 2014 - 2026)
    • Outpatient
    • Inpatient

• Regional Outlook (Revenue, USD Million, 2014 - 2026)
    • North America
        • U.S.
        • Canada
    • Europe
        • Germany
        • France
        • U.K.
        • Italy
        • Spain
        • Russia
    • Asia Pacific
        • Japan
        • China
        • India
        • South Korea
        • Australia
        • Singapore
    • Latin America
        • Brazil
        • Mexico
        • Argentina
    • Middle East & Africa
        • South Africa
        • Saudi Arabia
        • UAE

What questions do you have? Get quick response from our industry experts. Request More information
Key questions answered in the report include
key questions
We also offers customization on reports based on specific client requirement.
Request for Customization

Choose License Type

Research Assistance

Ryan Manuel
Ryan Manuel

Research Support Specialist, USA

  1. Phone: +1-408-610-2300
  2. Toll Free: +1-866-831-4085
  3. Email: [email protected]
  • World's largest premium report database
  • Transparent pre & post sale customer engagement model
  • Unparalleled flexibility in terms of rendering services
  • Safe & secure web experience
  • 24*5 Research support service
  • 100% Secure Payments
  • Our Promise
  • 100% Service Assurance
  • Market Monitoring
  • Service Flexibility
  • 24X5 Care available